Categories: PR Newswire

CERE MERGER ANNOUNCEMENT: Julie & Holleman LLP Announces Investigation Into Potential Claims Regarding AbbVie’s Proposed Acquisition of Cerevel Therapeutics

NEW YORK, Dec. 6, 2023 /PRNewswire/ — Julie & Holleman LLP, a nationally recognized shareholder rights law firm, is investigating the proposed $45 per share sale of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) to AbbVie Inc. The firm has already identified potential conflicts of interest related to the merger.



For a free consultation and to learn about our investigation, click here or visit: https://julieholleman.com/?p=3218

On December 6, 2023, Cerevel announced that it had entered into an agreement for the company to be acquired by AbbVie for $45 per share, or a total of $8.7 billion. The transaction, which is subject to shareholder approval, is expected to close in mid-2024.

Julie & Holleman, whose attorneys have helped secure hundreds of millions of dollars for shareholders, is concerned about potential conflicts, including related to Cerevel’s largest shareholder, Bain Capital.

If you would like more information about our investigation, please contact W. Scott Holleman at scott@julieholleman.com or (917) 325-3798, or submit your information by clicking here.

Julie & Holleman is a boutique law firm that focuses on shareholder litigation, including derivative actions, mergers and acquisitions cases, securities fraud class actions, and corporate investigations. The firm’s attorneys litigate in state and federal courts across the nation and have helped secure hundreds of millions of dollars for aggrieved companies and their shareholders. For more information about the firm, please visit https://www.julieholleman.com/. This notice may constitute attorney advertising. Past results do not guarantee future outcomes.

CONTACT INFORMATION

Julie & Holleman LLP
W. Scott Holleman, Esq.
157 East 86th Street
4th Floor
New York, NY 10028
(929) 415-1020
www.julieholleman.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/cere-merger-announcement-julie–holleman-llp-announces-investigation-into-potential-claims-regarding-abbvies-proposed-acquisition-of-cerevel-therapeutics-302008308.html

SOURCE Julie & Holleman LLP

Dayang Norazhar

Recent Posts

Businessman sues Chegubard, Taman Medan Assemblyman for defamation

KUALA LUMPUR – A businessman has filed a lawsuit against Badrul Hisham Shaharin, or “Chegubard”…

19 mins ago

The Kia EV9 powers a light installation to mimic the sun in Norway

The EV9 features Vehicle-to-Load (V2L) that enables appliances and power cables to be plugged into…

20 mins ago

Vantage Foundation partners with The IREDE Foundation to empower child amputees in Nigeria

LAGOS, Nigeria, Feb. 23, 2024 /CNW/ -- Vantage Foundation is proud to announce its strategic…

20 mins ago

TECNO to Unveil An AI-Enhanced Imaging System at MWC24, Set to Debut in its Upcoming CAMON 30 Series

The new TECNO PolarAce Imaging System harnesses AI, industry-first, and industry-leading technologies to level up…

25 mins ago

Lay’s Partners with Football Icons David Beckham and Thierry Henry to Surprise 75,000 Fans in Epic Return of ‘No Lay’s, No Game’

The 'No Lay's, No Game' platform is back with an in-stadium "Crisp Cam" stunt you…

25 mins ago

LEAP-market Metro Healthcare patient numbers go up

WOMEN healthcare specialist provider Metro Healthcare Bhd saw its net profit for the second half ended…

29 mins ago